A Study to Learn About the Study Medicine - Precedex in Children From Japan.

CompletedOBSERVATIONAL
Enrollment

111

Participants

Timeline

Start Date

October 18, 2023

Primary Completion Date

June 20, 2025

Study Completion Date

June 20, 2025

Conditions
Sedation
Interventions
DRUG

Dexmedetomidine Hydrochloride

"\<Sedation of non-invasive procedures and tests without intubation in pediatrics\> For children aged 2 years or older, the usual dosage of dexmedetomidine is 12 μg/kg/hr given as a continuous intravenous infusion over 10 minutes (initial loading dose) followed by a maintenance dose of 1.5 μg/kg/hr (maintenance dose).~For children aged 1 month to \< 2 years old, the usual dosage of dexmedetomidine is 9 μg/kg/hr given as a continuous intravenous infusion over 10 minutes (initial loading dose) followed by a maintenance dose of 1.5 μg/kg/hr (maintenance dose).~The infusion rate should be reduced according to patient's condition."

Trial Locations (1)

151-8589

Pfizer, Toykyo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT06085573 - A Study to Learn About the Study Medicine - Precedex in Children From Japan. | Biotech Hunter | Biotech Hunter